Global Peptide Synthesis Market Is Set For Moderate Growth, To Reach Around USD 955.7 Million By 2032

14-Jun-2024 | Zion Market Research

Zion Market Research has published a new report titled “Peptide Synthesis Market: Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 – 2032”. According to the report, the global demand for the peptide synthesis market was valued at approximately USD 603.6 million in 2023 and is expected to generate revenue of around USD 955.7 million by the end of 2032, growing at a CAGR of around 5.36% between 2024 and 2032.

Browse the full “Peptide Synthesis Market By Product (Equipment And Reagents), By Technology (Solid-Phase Peptide Synthesis, Liquid-Phase Peptide Synthesis, And Hybrid & Recombinant Technology), By End-User (Pharmaceutical & Biotechnological Companies, Contract Development & Manufacturing Organizations, And Academic & Research Institutes), By Region: Global Industry Perspective, Comprehensive Analysis And Forecast, 2024 - 2032” Report at https://www.zionmarketresearch.com/report/peptide-synthesis-market

Global Peptide Synthesis Market Size

Peptide production is referred to as peptide synthesis. A peptide is a long sequence of multiple amino acids that are linked together via amide or peptide bonds. These peptides can be chemically manufactured synthetically by the condensation reaction of the carboxyl group of one amino acid to the amino group of another. The chemical synthesis starts usually at the C-terminus (carboxyl end) of one amino acid and proceeds towards the N-terminus (amino terminus) opposite to what occurs in living organisms.

The global peptide synthesis market growth is fueled by various factors like the rising use of peptides in pharmaceutical drug development, the development of advanced peptide synthesizers, the availability of funding for R&D and an increase in research activities. Also, growth is supported by increasing novel therapeutic peptide development projects, high unmet medical needs and increasing chronic disease burden. However, the lack of an amalgamated set of regulations may act as a restraining factor that may limit the market growth during the forecast period. Emerging markets such as India and China with booming biopharmaceutical industries are projected to open new opportunities for the peptide synthesis market.

The peptide synthesis market is segmented based on technology, end-user, product, and region. Based on product, the market is segmented into reagents and equipment. In 2023, the reagents product segment dominated the market owing to the frequent and continuous use of reagents for routine peptide development studies and research. The fastest growth is projected for the equipment segment over the forecast period. Technological advancements and production process optimization using advanced equipment and large-volume production contribute to the fast growth of the equipment segment. Chromatography equipment, lyophilizers, and peptide synthesizers are sub-segments of the equipment product segment.

Based on technology, the global peptide synthesis market is segmented into liquid-phase peptide synthesis, hybrid and recombinant technology and solid-phase peptide synthesis. Solid-phase peptide synthesis technology is widely used due to various advantages like easy and inexpensive scale-up, large volume and high-quality peptide production. Rapid growth is projected for hybrid and recombinant technology over the forecast period due to swift growth in the biopharmaceutical industry.

Contract development and manufacturing organizations, pharmaceutical & biotechnological companies and academic & research institutes are end users of the market. Pharmaceutical & biotechnological companies held the largest market share in 2023 owing to increasing investments in novel therapeutic peptide development by major pharmaceutical and biopharmaceutical companies.

Peptide Synthesis Market

At the regional level, North America held the dominating revenue share in 2023 for the global peptide synthesis market. This large share is attributed to the availability of developed R&D infrastructure, the presence of major manufacturers, the availability of funds, increasing chronic disease burdens like cancer, obesity, diabetes, etc., and technological advancements. Europe held the second-largest market share. Increasing R&D expenditure for novel peptide therapeutic development and the presence of technologically advanced R&D infrastructure are factors likely to fuel market growth in this region. Latin America is projected to witness moderate growth during the forecast period. Asia Pacific region will exhibit the fastest growth rate over the forecast period for the peptide synthesis market. Increasing prevalence of chronic diseases like diabetes, cancer, infectious diseases, etc., maturing pharmaceutical and biopharmaceutical industry in emerging countries like India and China, along with government funding are projected to be market growth boosting in the coming years. Middle East and Africa will witness slow growth over the forecast period due to poor R&D infrastructure and lack of funds. 

Major players included in the report are GenScript Biotech Corporation, AAPPTec, Bachem, AnaSpec, Biotage, CEM Corporation, Gyros Protein Technologies, New England Peptide, Merck KGaA and Advanced ChemTech among others.

The report segments of global peptide synthesis market as follows:

Global Peptide Synthesis Market: By Product

  • Reagents
  • Equipment
    • Peptide Synthesizers
    • Chromatography equipment
    • Lyophilizers

Global Peptide Synthesis Market: By Technology

  • Solid-phase Peptide Synthesis
  • Liquid-phase Peptide Synthesis
  • Hybrid & Recombinant Technology

Global Peptide Synthesis Market: By End-User

  • Pharmaceutical and Biotechnology Companies
  • Contract Development and Manufacturing Organizations
  • Academic and Research Institutes

Global Peptide Synthesis Market: By Region

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

About Us:
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.

Contact Us:
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651
Email: sales@zionmarketresearch.com
Website: https://www.zionmarketresearch.com

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed